Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide Marco C. Merlano, Anna M. Merlotti, Lisa Licitra, Nerina Denaro, Elena Fea, Danilo Galizia, Massimo Di Maio, Claudia Fruttero, Paola Curcio, Stefania Vecchio, Elvio G. Russi, Renzo Corvò Clinical and Translational Radiation Oncology Volume 12, Pages 47-52 (August 2018) DOI: 10.1016/j.ctro.2018.08.001 Copyright © 2018 The Authors Terms and Conditions
Fig. 1 Study schema. Clinical and Translational Radiation Oncology 2018 12, 47-52DOI: (10.1016/j.ctro.2018.08.001) Copyright © 2018 The Authors Terms and Conditions